Laxmi Organic Industries Ltd (LXCHEM)
🎯 Key Takeaways
- Laxmi Organic Industries Ltd (LXCHEM) is in a strategic transition phase, shifting from operational instability to structured growth through targeted capital allocation and expansion of manufacturing infrastructure, though profitability remains volatile. The company is leveraging reallocated R&D funds and ESOP-driven equity issuance to scale operations, but margin recovery is still in progress amid macroeconomic headwinds.
- Revenue grew 31.7% QoQ to ₹968 in Q1FY27.
- ⚠️ 1) Margin recovery is still incomplete, with OPM at 9.6% in June 2026 — below sector benchmarks — and vulnerable to raw material cost volatility. 2) T
- Market Cap
- ₹4,882
- P/E Ratio
- 38.9
- P/B Ratio
- 2.46
- ROE
- 6.3%
- ROCE
- 7.4%
- Debt/Equity
- 0.27
- Div Yield
- 0.17%
- Promoter
- 69.3%
📖 The Story
Laxmi Organic Industries Ltd (LXCHEM) is in a strategic transition phase, shifting from operational instability to structured growth through targeted capital allocation and expansion of manufacturing infrastructure, though profitability remains volatile. The company is leveraging reallocated R&D funds and ESOP-driven equity issuance to scale operations, but margin recovery is still in progress amid macroeconomic headwinds.
📰 What's Happening
In Q2FY27, the company allotted 703,126 shares under ESOP-2020, diluting ownership without cash impact, while simultaneously reallocating unused funds from the Mahape innovation center project to the Dahej manufacturing expansion pending shareholder approval. The 37th AGM confirmed audited FY2026 financials and declared a final dividend, signaling governance stability. Management confirmed no deviation in QIP fund utilization per SEBI regulations, validating compliance and strategic redirection of capital toward high-potential manufacturing capacity. Shareholder voting on fund reallocation is scheduled by December 2025, marking a pivotal step in operational scaling.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 700 | 719 | 735 | 968 |
| Operating Profit | 17 | 29 | 34 | 93 |
| OPM % | 2.5% | 4.1% | 4.7% | 9.6% |
| Net Profit | 11 | 25 | 22 | 68 |
| EPS | ₹0.41 | ₹0.92 | ₹-0.77 | ₹2.44 |
Revenue has shown sequential improvement, rising from ₹700 crore in September 2025 to ₹968 crore in June 2026, driven by operational ramp-up, though profitability remains uneven with OPM expanding from 2.5% to 9.6% over the same period. Net profit turned positive in December 2025 after a loss in September 2025, and EPS improved from ₹0.41 to ₹2.44, reflecting better cost control and volume gains. However, margins are still below industry potential, indicating ongoing integration challenges in the new manufacturing setup.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or margin targets in the reviewed filings, but actions suggest a focus on scaling Dahej capacity and monetizing innovation investments. The reallocation of QIP funds to Dahej and pending shareholder approval for fund usage underscore a shift from R&D experimentation to commercial production. The absence of formal guidance implies confidence in execution rather than public projection, with progress tied to shareholder validation of capital deployment.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 55 | 56 | 55 | 55 |
| Reserves | 1,851 | 1,800 | 1,930 | 1,873 |
| Borrowings | 258 | 200 | 541 | 334 |
| Total Liabilities | 3,045 | 2,828 | 3,446 | 3,196 |
| Fixed Assets | 1,166 | 903 | 1,481 | 1,437 |
| Investments | 148 | 192 | 37 | 63 |
| Total Assets | 3,045 | 2,828 | 3,446 | 3,196 |
The balance sheet shows a stable capital structure with modest leverage (D/E of 0.27) and growing reserves, indicating conservative financial management. Borrowings increased slightly from ₹258 crore to ₹334 crore, likely to fund expansion, while equity remains flat at ₹55 crore, reflecting limited new issuances beyond ESOP dilution. Total assets grew from ₹3,045 crore to ₹3,446 crore, signaling asset base expansion, but capital intensity appears managed without aggressive debt accumulation.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +175 |
| Investing | -404 |
| Financing | +247 |
| Net Cash Flow | +19 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 69.3% | 69.3% | 69.3% | 69.3% |
| FII | 1.6% | 1.6% | 1.1% | 0.7% |
| DII | 3.2% | 3.4% | 3.8% | 3.8% |
| Public | 21.9% | 22.1% | 22.2% | 22.6% |
| # Shareholders | 3,62,107 | 3,50,899 | 3,40,436 | 3,35,793 |
Promoter holding remains stable at 69.34–69.35%, indicating confidence in long-term prospects, while FII ownership rose from 1.15% to 1.6% over four quarters, suggesting growing institutional interest. DII holdings are steady around 3.5–3.8%, and the shareholder base has slightly contracted, possibly due to ESOP dilution. The rise in FII participation, despite flat promoter stake, reflects increasing market validation of the company’s turnaround narrative.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | — | 0.01 |
| SRF | 72,171 | 33.4 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,799 | 96.6 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,503 | 79.3 | 9.6% | — | 0.34 |
| NAVINFLUOR | 42,232 | 53.4 | 22.2% | — | 0.31 |
| GODREJIND | 35,513 | 30.2 | 9.2% | — | 4.57 |
| HSCL | 33,663 | 41.8 | 20.7% | — | 0.16 |
| AETHER | 23,246 | 98.6 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,783 | 26.5 | 15.3% | — | 0.26 |
| CASTROLIND | 19,792 | 18.6 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Margin recovery is still incomplete, with OPM at 9.6% in June 2026 — below sector benchmarks — and vulnerable to raw material cost volatility. 2) The Dahej expansion depends on shareholder approval of fund reallocation, creating execution and timing risk if delayed beyond December 2025. 3) Persistent net loss in early quarters (e.g., ₹-0.77 EPS in March 2026) highlights ongoing operational volatility, and lack of formal guidance suggests uncertainty in profitability timelines. 4) Low public shareholding turnover and concentrated promoter control may limit liquidity and governance scrutiny.
📋 Recent Filings
- Announcement2026-09-28Laxmi Organic Industries Ltd announced that its trading window will close from October 1, 2026 until 48 hours after the board meeting to approve un-au…
- 🟡 Board Meeting2026-09-08Laxmi Organic Industries announced a planned leadership transition effective November 13-14, 2026, with Dr. Rajan Venkatesh resigning as MD & CEO and …
- Announcement2026-08-18Laxmi Organic Industries Limited announced the resignation of Dr. Keshav Ruthia, Chief Procurement Officer, and Mr. Salil Mukundan, Chief Technology O…
- 🟡 Board Meeting2026-08-18No summary available
- 🟡 Board Meeting2026-08-13Laxmi Organic Industries announced the allotment of 703,126 equity shares at ₹2 each under its ESOP-2020 scheme, increasing share capital from [amount…
- 🟡 Board Meeting2026-08-05Laxmi Organic Industries held its 37th AGM on August 5, 2026 via video conference, adopting audited standalone and consolidated financial statements f…
- Announcement2026-08-04Laxmi Organic Industries Limited (LXCHEM) reported robust Q1 FY27 results with 40% YoY revenue growth to [amount not verified] and EBITDA surging 272%…
- Announcement2026-07-30Laxmi Organic Industries Limited announced that a recording of its analyst and institutional investor meeting for the quarter ended June 30, 2026, hel…
- 🟡 deviation variation2026-07-30Laxmi Organic Industries Limited confirmed no deviation in QIP fund utilization for the quarter ended June 30, 2026, as per India Ratings' monitoring …
- 🟡 Board Meeting2026-07-29Laxmi Organic Industries Limited announced the Board approved unaudited standalone and consolidated financial results for Q1 June 2026 on July 29, 202…
🧠 Analyst's Read
Laxmi Organic Industries is executing a capital-light expansion with disciplined fund reallocation and improving operational trends, but profitability remains fragile and execution-dependent. Investors should monitor shareholder approval of Dahej fund reallocation and subsequent margin trends in upcoming quarters to assess the sustainability of the turnaround.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when LXCHEM files new disclosures
Track LXCHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track LXCHEM — FreeFree account · 2 AI queries/day